Our findings thus suggest that circulating autoreactive CD4 T cells in AILD are imprinted by chronic antigen exposure to promote liver inflammation, thereby serving as a potential target for developing biomarkers and therapies for AILD. The gene discussed is CD4; the disease is angioimmunoblastic T-cell lymphoma.